VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 101 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 17.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,154,000 | -38.7% | 438,767 | -3.7% | 0.01% | -38.5% |
| Q2 2021 | $1,882,000 | -28.8% | 455,663 | -18.9% | 0.01% | -35.0% |
| Q1 2021 | $2,645,000 | +240.0% | 561,669 | +416.3% | 0.02% | +185.7% |
| Q4 2020 | $778,000 | -12.7% | 108,784 | +30.2% | 0.01% | -22.2% |
| Q3 2020 | $891,000 | +11.8% | 83,545 | +32.3% | 0.01% | 0.0% |
| Q2 2020 | $797,000 | +486.0% | 63,126 | +323.6% | 0.01% | +350.0% |
| Q1 2020 | $136,000 | -22.3% | 14,901 | +19.1% | 0.00% | 0.0% |
| Q4 2019 | $175,000 | -78.7% | 12,510 | -73.7% | 0.00% | -80.0% |
| Q3 2019 | $820,000 | +0.6% | 47,630 | +59.1% | 0.01% | -9.1% |
| Q2 2019 | $815,000 | -26.8% | 29,940 | -48.5% | 0.01% | -31.2% |
| Q1 2019 | $1,113,000 | +328.1% | 58,145 | +337.2% | 0.02% | +300.0% |
| Q2 2018 | $260,000 | – | 13,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |